Copertina

Identification of conserved RNA secondary structures in human Respiratory Syncytial Virus A (hRSV)

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autori principali:	Dabiri, Damilare, Rouse, Warren, Moss, Walter
Natura:	Recurso digital
Pubblicazione:	Zenodo 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Mucin‐Inspired Filamentous Sulfated Copolymers Effectively Inhibit Human Respiratory Syncytial Virus (hRSV) Infectivity
di: Raju Bej, et al.
Pubblicazione: (2025)

The Persistent Respiratory Impact of Respiratory Syncytial Virus (RSV) Bronchiolitis in Infants
di: Elif Çelik, et al.
Pubblicazione: (2026)

Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV
di: Atsuko Yamamoto, et al.
Pubblicazione: (2024)

Respiratory Syncytial Virus (RSV)‐Related Hospitalization and Increased Rate of Cardiovascular Events in Older Adults
di: Chris P. Verschoor, et al.
Pubblicazione: (2025)

Positivity and Boundedness of Solutions for a Stochastic Seasonal Epidemiological Model for Respiratory Syncytial Virus (RSV)
di: Gilberto Gonzalez Parra
Pubblicazione: (2017)

Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections
di: Morgan D. McSweeney, et al.
Pubblicazione: (2024)

Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review
di: Richard Osei‐Yeboah, et al.
Pubblicazione: (2024)

Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study
di: Keren Armoni Domany, et al.
Pubblicazione: (2025)

Respiratory Syncytial Virus (RSV) in an Italian Pediatric Cohort: Genomic Analysis and Circulation Pattern in the Season 2022–2023
di: Alessia Lai, et al.
Pubblicazione: (2025)

Chapter 5 Respiratory Syncytial Virus
di: Jha, Akhilesh, et al.
Pubblicazione: (2021)

Comparison of the Burden and Temporal Pattern of Hospitalisations Associated With Respiratory Syncytial Virus (RSV) Before and After COVID‐19 in New Zealand
di: Nikki Turner, et al.
Pubblicazione: (2024)

Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)]
di: G. Sever Yildiz, et al.
Pubblicazione: (2024)

The Impact of Limited‐Eligibility Nirsevimab on Paediatric Respiratory Syncytial Virus ( RSV ) Infection and Hospitalisations in the Australian Capital Territory: An Observational Cohort Study
di: Nicola Irwin, et al.
Pubblicazione: (2026)

A Self‐Assembled RSV‐DS2 Based Nanovaccine Elicits a Strong Immune Response Against Respiratory Syncytial Virus Infection
di: Entao Li, et al.
Pubblicazione: (2025)

Chiral Intranasal Nanovaccines as Antivirals for Respiratory Syncytial Virus
di: Baimei Shi, et al.
Pubblicazione: (2024)

Spatial Transmission Dynamics of Respiratory Syncytial Virus A in China
di: Bin Yan, et al.
Pubblicazione: (2025)

Correction to: The Respiratory Syncytial Virus Prefusion F Protein Vaccine Attenuates the Severity of RSV‐Associated Disease in Breakthrough Infections in Adults ≥60 Years of Age
Pubblicazione: (2024)

Host Immune Response to Respiratory Syncytial Virus Infection in Children
di: Gang Chen, et al.
Pubblicazione: (2025)

Inferring Transmission Dynamics of Respiratory Syncytial Virus from Houston Wastewater
di: Palacio, Jose R., et al.
Pubblicazione: (2025)

Photoinduced Cleavage of Respiratory Syncytial Virus by Chiral Vanadium Trioxide Nanoparticles
di: Baimei Shi, et al.
Pubblicazione: (2025)

The Impact of COVID‐19 Pandemic on Respiratory Syncytial Virus Infection in Children
di: Jose Boris Trigueros Montes, et al.
Pubblicazione: (2024)

Should We Vaccinate Healthcare Workers Against Respiratory Syncytial Virus?
di: Klinger Soares Faico‐Filho, et al.
Pubblicazione: (2024)

Variability in the Timing of Respiratory Syncytial Virus Epidemics in Guatemala, 2008–2018
di: Sarah Hamid, et al.
Pubblicazione: (2024)

Prevalence of Influenza Viruses A and B, Adenovirus, Respiratory Syncytial Virus, and Human Metapneumonia Viruses among Children with Acute Respiratory Tract Infection
di: Rana Farzi, et al.
Pubblicazione: (2024)

Birth Month Matters in Timing of Seasonal Prevention of Severe Respiratory Syncytial Virus
di: Caroline K. Johannesen, et al.
Pubblicazione: (2025)

Development and Validation of Amplicon‐Based Protocol for Sequencing of Respiratory Syncytial Virus Genome
di: Guglielmo Ferrari, et al.
Pubblicazione: (2025)

Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital
di: Koos Korsten, et al.
Pubblicazione: (2025)

Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus
di: Han Zhang, et al.
Pubblicazione: (2025)

Modeling of Pneumococcal and Respiratory Syncytial Virus Pneumonia: An Epidemiological Review, with Statistical Inference
di: Sutradhar, Rupchand, et al.
Pubblicazione: (2026)

Clinical Outcomes of Respiratory Syncytial Virus Infection Among Pediatric Immunocompromised Hosts
di: Hailey S. Ross, et al.
Pubblicazione: (2024)

ZNRD2 Mediated Nucleoprotein Aggregation Impairs Respiratory Syncytial Virus Replication
di: Haiwu Zhou, et al.
Pubblicazione: (2026)

Epidemic Outbreak of Respiratory Syncytial Virus Infection After the end of the Zero‐COVID‐19 Policy in China: Molecular Characterization and Disease Severity Associated With a Novel RSV‐B Clade
di: Yulin Zhang, et al.
Pubblicazione: (2025)

A Study on Clinical Features of Respiratory Syncytial Virus in Acute Respiratory Tract Infection in Elderly Hospitalized Patients in Winter
di: Xuedan Li, et al.
Pubblicazione: (2026)

Unequal Access to Respiratory Syncytial Virus Prevention: Is There a Health Equity Issue in Italy?
di: Maurizio Aricò, et al.
Pubblicazione: (2025)

Impact of COVID‐19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children
di: Yingfeng Lu, et al.
Pubblicazione: (2024)

Bronchiolitis Severity Scores for Predicting Mechanical Ventilation Needs in Children With Respiratory Syncytial Virus
di: Ayu Ogura Kawakami, et al.
Pubblicazione: (2026)

Impact of Nirsevimab on RSV and Non‐RSV Severe Respiratory Infections in Hospitalized Infants
di: María Luz García‐García, et al.
Pubblicazione: (2025)

Cost‐Effectiveness Analysis of a Maternal Vaccination Program Against Respiratory Syncytial Virus in Norway
di: Susanne Gerda Værnø, et al.
Pubblicazione: (2025)

In Response to ‘Unequal Access to Respiratory Syncytial Virus Prevention: Is There a Health Equity Issue in Italy?’
di: Juan Manuel Rius‐Peris, et al.
Pubblicazione: (2025)

Metabolomics and Network Pharmacology Revealed the Mechanism of Feining Mixture Against Respiratory Syncytial Virus Pneumonia
di: Chengdou Xie, et al.
Pubblicazione: (2025)